Medicinal grade opium tincture for severe diarrhea: effect revisited in observational study

被引:4
作者
Dahlgren, David [1 ,3 ]
Hellstrom, Per M. [2 ]
机构
[1] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden
[2] Uppsala Univ, Dept Med Sci Gastroenterol & Hepatol, Uppsala, Sweden
[3] Dept Pharmaceut Biosci, Box 591, SE-75124 Uppsala, Sweden
关键词
chemotherapy; codeine; constipation; morphine; opium tincture; stool; OPIOID-INDUCED CONSTIPATION; SYMPTOMATIC TREATMENT; MORPHINE-METABOLISM; CANCER-PATIENTS; LOPERAMIDE; MANAGEMENT; PLACEBO; PHARMACOKINETICS; BIOAVAILABILITY; TOLERANCE;
D O I
10.1097/MOG.0000000000000985
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of reviewChronic diarrhea is a common disorder that interferes with normal daily activities and results in poor quality of life. Fecal urgency and incontinence often necessitate clinical consultation, but the pathophysiological mechanisms are difficult to differentiate in a clinical setting. Therefore, drugs targeting the opioid receptors, such as diphenoxylate and loperamide, are typically used, as they reduce both gut motility and secretion.Recent findingsFor severe diarrhea, morphine-containing extemporaneous opium tincture drops have recently been reprofiled to a pharmaceutical. The drug is indicated for severe diarrhea in adults when other antidiarrheals do not give sufficient fecal emptying control. The pronounced effect is due to the liquid formulation with rapid onset as a drug dissolution step is avoided. A recent prospective, noninterventional study (CLARIFY) of patients treated with opioid drops demonstrates a rapid and sustained therapeutic effect. Tolerance does not develop for the antidiarrheal effect and no dependence was observed after discontinuation.SummaryThis mini-review discusses the use of opium derivates for treatment of diarrhea, with an emphasis on opium drops as a new medicinal grade opium for the use as additional treatment of severe diarrhea, emphasizing its mechanism of action and evaluation of the risk-benefit ratio in the clinical setting.
引用
收藏
页码:196 / 202
页数:7
相关论文
共 42 条
[1]   Site and mechanism of morphine tolerance in the gastrointestinal tract [J].
Akbarali, H. I. ;
Inkisar, A. ;
Dewey, W. L. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (10) :1361-1367
[2]  
[Anonymous], 2023, European Pharmacopeia
[3]   Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition [J].
Arasaradnam, Ramesh P. ;
Brown, Steven ;
Forbes, Alastair ;
Fox, Mark R. ;
Hungin, Pali ;
Kelman, Lawrence ;
Major, Giles ;
O'Connor, Michelle ;
Sanders, Dave S. ;
Sinha, Rakesh ;
Smith, Stephen Charles ;
Thomas, Paul ;
Walters, Julian R. F. .
GUT, 2018, 67 (08) :1380-+
[4]  
Baker DE, 2007, REV GASTROENTEROL DI, V7, pS11
[5]   QUANTITATIVE, NONINVASIVE ASSESSMENT OF ANTIDIARRHEAL ACTIONS OF CODEINE USING AN EXPERIMENTAL-MODEL OF DIARRHEA IN MAN [J].
BARROW, L ;
STEED, KP ;
SPILLER, RC ;
MASKELL, NA ;
BROWN, JK ;
WATTS, PJ ;
MELIA, CD ;
DAVIES, MC ;
WILSON, CG .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (06) :996-1003
[6]   Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis [J].
Black, Christopher J. ;
Burr, Nicholas E. ;
Camilleri, Michael ;
Earnest, David L. ;
Quigley, Eamonn M. M. ;
Moayyedi, Paul ;
Houghton, Lesley A. ;
Ford, Alexander C. .
GUT, 2020, 69 (01) :74-82
[7]  
BRUNK SF, 1974, CLIN PHARMACOL THER, V16, P51
[8]  
Campbell S., 2021, BMJ Best Pract
[9]   ROLE OF LOPERAMIDE AND PLACEBO IN MANAGEMENT OF IRRITABLE BOWEL SYNDROME (IBS) [J].
CANN, PA ;
READ, NW ;
HOLDSWORTH, CD ;
BARENDS, D .
DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (03) :239-247
[10]   Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies [J].
Dahlgren, David ;
Sjoblom, Markus ;
Hellstrom, Per M. ;
Lennernas, Hans .
FRONTIERS IN PHARMACOLOGY, 2021, 12